Cite Filings / ADAPY / 0001104659-23-030593

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

Adaptimmune Therapeutics PLC Filed 2023-03-09 Acc 0001104659-23-030593

Documents 1

425 Prospectus/Communication re Business Combination , tm238549d3_425.htm

Around this filing

2023-03-10 8-K Regulation FD disclosure
2023-03-09 425 Prospectus/Communication re Business Combination
2023-03-09 425 Prospectus/Communication re Business Combination
2023-03-06 10-K Annual Report
2023-03-06 8-K Agreement ended · Results of operations · Executive or director change
2023-03-06 425 Prospectus/Communication re Business Combination
2023-03-06 8-K Material agreement · Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm238549d3_425.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…